Please Wait
Applying Filters...
menu
    • menu
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    Inke S.A: APIs manufacturing plant.

    Virtual Booth

    Contact Supplier

    xyz-pharma-2025-04-21

    Virtual Booth

    An Enquiry

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-04-28

    Virtual Booth

    An Enquiry

    Menu

    Ecofenac

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 32Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Enforcement Report - Week of January 8, 2025
    Enforcement Report - Week of January 8, 2025

    08 Jan 2025

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-8-2025-53657.pdf

    FDA
    08 Jan 2025
    Share Share
    GNMART Inc Issues Voluntary Nationwide Recall of Force Forever
    GNMART Inc Issues Voluntary Nationwide Recall of Force Forever

    16 Dec 2024

    // FDA

    https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/gnmart-inc-issues-voluntary-nationwide-recall-force-forever-due-undeclared-drug-ingredients

    FDA
    16 Dec 2024
    Share Share
    Enforcement Report - Week of December 11, 2024
    Enforcement Report - Week of December 11, 2024

    11 Dec 2024

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-december-11-2024-90405.pdf

    FDA
    11 Dec 2024
    Share Share
    Mxbbb Issues Voluntary Nationwide Recall of Umary
    Mxbbb Issues Voluntary Nationwide Recall of Umary

    21 Nov 2024

    // FDA

    https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/mxbbb-issues-voluntary-nationwide-recall-umary-acid-hyaluronic-due-presence-diclofenac-and

    FDA
    21 Nov 2024
    Share Share
    Enforcement Report - Week of November 20, 2024
    Enforcement Report - Week of November 20, 2024

    20 Nov 2024

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-20-2024-11761.pdf

    FDA
    20 Nov 2024
    Share Share
    VitalityVita Issues Voluntary Nationwide Recall of VitalityXtra Capsules
    VitalityVita Issues Voluntary Nationwide Recall of VitalityXtra Capsules

    06 Nov 2024

    // FDA

    https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/vitalityvita-issues-voluntary-nationwide-recall-vitalityxtra-and-peakmax-capsules-due-presence

    FDA
    06 Nov 2024
    Share Share